Skip to main navigation
Skip to search
Skip to main content
UTMB Health Research Expert Profiles Home
Help & FAQ
Home
Experts
Departments
Equipment
Projects/Grants
Publications
Activities
Press/Media
Honors
Impacts
Search by expertise, name or affiliation
Embryonic Ectoderm Development (EED) as a Novel Target for Cancer Treatment
Nicholas Cook
, Jianping Chen
,
Jia Zhou
, Daqing Wu
Pharmacology & Toxicology
Research output
:
Contribution to journal
›
Article
›
peer-review
7
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Embryonic Ectoderm Development (EED) as a Novel Target for Cancer Treatment'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Cancer Treatment
100%
Polycomb Repressive Complex 2 (PRC2)
100%
Embryonic Ectoderm Development
100%
H3K27me3
40%
Small Molecules
20%
2-complex
20%
Dysregulated
20%
Lysine
20%
Allosteric Site
20%
Histone H3
20%
Core Protein
20%
Gene Silencing
20%
Trimethylation
20%
Enhancer of Zeste Homolog 2 (EZH2)
20%
Three-core
20%
SUZ12
20%
Biochemistry, Genetics and Molecular Biology
Polycomb Repressive Complex 2
100%
Epiblast
100%
Ectoderm
100%
Small Molecule
20%
Histone H3
20%
EZH2
20%
Gene Inactivation
20%
Allosteric Site
20%
SUZ12
20%
Lysine
20%